In the last 12 months, insiders at Cytosorbents Corp ($CTSO) filed 124 transactions with the SEC: 28 open-market purchases totaling $402,298 and 0 sales totaling $0. Net insider sentiment: net buying.
Cytosorbents Corp operates in the Surgical & medical instruments & apparatus industry (Industrial Applications and Services sector).
Most Active Insiders
- Chan Phillip P. (Chief Executive Officer) — 19 transactions totaling $381,131
- MARIANI PETER J (Chief Financial Officer) — 16 transactions totaling $116,761
- BATOR MICHAEL G. (Director) — 14 transactions totaling $86,760
- Sobel Alan D. (Director) — 13 transactions totaling $76,755
- BLOCH KATHLEEN P. (Chief Financial Officer) — 7 transactions totaling $50,000
View all SEC Filings for Cytosorbents Corp (CTSO).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 18, 2025 | Chan Phillip P. | Chief Executive Officer | A | Common Stock | 100000 | $0.64 | 1,482,963.0000 | 62,753,959 | 7.23% | 0.16% |
| Aug. 8, 2025 | MARIANI PETER J | Chief Financial Officer | A | Stock Option (Right to Buy) | 90000 | $0.00 | 90,000.0000 | 67,166,377 | 9999.99% | 0.13% |
| Aug. 8, 2025 | Kim Jiny | Director | A | Stock Option (Right to Buy) | 22000 | $0.00 | 22,000.0000 | 67,166,377 | 9999.99% | 0.03% |
| Aug. 8, 2025 | Capponi Vincent | President and COO | A | Common Stock | 89100 | $0.00 | 766,268.0000 | 67,166,377 | 13.16% | 0.13% |
| Aug. 8, 2025 | Capponi Vincent | President and COO | A | Stock Option (Right to Buy) | 111100 | $0.00 | 111,100.0000 | 67,166,377 | 9999.99% | 0.17% |
| Aug. 8, 2025 | Deliargyris Efthymios | Chief Medical Officer | A | Common Stock | 70000 | $0.00 | 473,025.0000 | 67,166,377 | 17.37% | 0.10% |
| Aug. 8, 2025 | Deliargyris Efthymios | Chief Medical Officer | A | Stock Option (Right to Buy) | 95000 | $0.00 | 95,000.0000 | 67,166,377 | 9999.99% | 0.14% |
| Aug. 8, 2025 | Sobel Alan D. | Director | A | Stock Option (Right to Buy) | 22000 | $0.00 | 22,000.0000 | 67,166,377 | 9999.99% | 0.03% |
| Aug. 8, 2025 | Chan Phillip P. | Chief Executive Officer | A | Common Stock | 105600 | $0.00 | 1,382,963.0000 | 67,166,377 | 8.27% | 0.16% |
| Aug. 8, 2025 | BATOR MICHAEL G. | Director | A | Stock Option (Right to Buy) | 44000 | $0.00 | 44,000.0000 | 67,166,377 | 9999.99% | 0.07% |
| Aug. 8, 2025 | Jones Edward Raymond | Director | A | Stock Option (Right to Buy) | 22000 | $0.00 | 22,000.0000 | 67,166,377 | 9999.99% | 0.03% |
| Aug. 8, 2025 | MARIANI PETER J | Chief Financial Officer | A | Common Stock | 71500 | $0.00 | 538,113.0000 | 67,166,377 | 15.32% | 0.11% |
| Aug. 8, 2025 | Chan Phillip P. | Chief Executive Officer | A | Stock Option (Right to Buy) | 136400 | $0.00 | 136,400.0000 | 67,166,377 | 9999.99% | 0.20% |
| Feb. 24, 2025 | BATOR MICHAEL G. | Director | O | Common Stock | 10000 | $1.13 | 151,273.0000 | 54,434,609 | 7.08% | 0.02% |
| Feb. 24, 2025 | BATOR MICHAEL G. | Director | O | Series A Right Warrants (right to buy) | 15879 | $1.13 | 0.0000 | 54,434,609 | 100.00% | 0.03% |
| Feb. 24, 2025 | Chan Phillip P. | Chief Executive Officer | O | Common Stock | 34168 | $1.13 | 1,277,363.0000 | 54,434,609 | 2.75% | 0.06% |
| Feb. 24, 2025 | Chan Phillip P. | Chief Executive Officer | O | Series A Right Warrants (right to buy) | 34168 | $1.13 | 0.0000 | 54,434,609 | 100.00% | 0.06% |
| Feb. 24, 2025 | Sobel Alan D. | Director | O | Common Stock | 21950 | $1.13 | 147,757.0000 | 54,434,609 | 17.45% | 0.04% |
| Feb. 24, 2025 | Sobel Alan D. | Director | O | Series A Right Warrants (right to buy) | 21950 | $1.13 | 0.0000 | 54,434,609 | 100.00% | 0.04% |
| Feb. 24, 2025 | Capponi Vincent | President and COO | O | Common Stock | 12000 | $1.13 | 677,168.0000 | 54,434,609 | 1.80% | 0.02% |
| Feb. 24, 2025 | MARIANI PETER J | Chief Financial Officer | O | Common Stock | 32625 | $1.13 | 466,613.0000 | 54,434,609 | 7.52% | 0.06% |
| Feb. 24, 2025 | Capponi Vincent | President and COO | O | Series A Right Warrants (right to buy) | 12000 | $1.13 | 0.0000 | 54,434,609 | 100.00% | 0.02% |
| Feb. 24, 2025 | MARIANI PETER J | Chief Financial Officer | O | Series A Right Warrants (right to buy) | 32625 | $1.13 | 0.0000 | 54,434,609 | 100.00% | 0.06% |
| Jan. 17, 2025 | MARIANI PETER J | Chief Financial Officer | J | Series B Right Warrants | 32625 | $0.00 | 32,625.0000 | 54,434,609 | 9999.99% | 0.06% |
| Jan. 17, 2025 | MARIANI PETER J | Chief Financial Officer | J | Series A Right Warrants | 32625 | $0.00 | 32,625.0000 | 54,434,609 | 9999.99% | 0.06% |
| Jan. 17, 2025 | BATOR MICHAEL G. | Director | X | Common Stock | 15879 | $1.00 | 141,273.0000 | 54,434,609 | 12.66% | 0.03% |
| Jan. 17, 2025 | BATOR MICHAEL G. | Director | X | Subscription Rights (right to buy) | 15879 | $0.00 | 0.0000 | 54,434,609 | 100.00% | 0.03% |
| Jan. 17, 2025 | BATOR MICHAEL G. | Director | J | Series A Right Warrants | 15879 | $0.00 | 15,879.0000 | 54,434,609 | 9999.99% | 0.03% |
| Jan. 17, 2025 | BATOR MICHAEL G. | Director | J | Series B Right Warrants | 15879 | $0.00 | 15,879.0000 | 54,434,609 | 9999.99% | 0.03% |
| Jan. 17, 2025 | Capponi Vincent | President and COO | X | Common Stock | 31760 | $1.00 | 665,168.0000 | 54,434,609 | 5.01% | 0.06% |
| Jan. 17, 2025 | Capponi Vincent | President and COO | X | Subscription Rights (right to buy) | 31760 | $0.00 | 0.0000 | 54,434,609 | 100.00% | 0.06% |
| Jan. 17, 2025 | Capponi Vincent | President and COO | J | Series A Right Warrants | 31760 | $0.00 | 31,760.0000 | 54,434,609 | 9999.99% | 0.06% |
| Jan. 17, 2025 | Capponi Vincent | President and COO | J | Series B Right Warrants | 31760 | $0.00 | 31,760.0000 | 54,434,609 | 9999.99% | 0.06% |
| Jan. 17, 2025 | Deliargyris Efthymios | Chief Medical Officer | X | Common Stock | 16233 | $1.00 | 403,025.0000 | 54,434,609 | 4.20% | 0.03% |
| Jan. 17, 2025 | Deliargyris Efthymios | Chief Medical Officer | X | Subscription Rights (right to buy) | 16233 | $0.00 | 0.0000 | 54,434,609 | 100.00% | 0.03% |
| Jan. 17, 2025 | Deliargyris Efthymios | Chief Medical Officer | J | Series A Right Warrants | 16233 | $0.00 | 16,233.0000 | 54,434,609 | 9999.99% | 0.03% |
| Jan. 17, 2025 | Deliargyris Efthymios | Chief Medical Officer | J | Series B Right Warrants | 16233 | $0.00 | 16,233.0000 | 54,434,609 | 9999.99% | 0.03% |
| Jan. 17, 2025 | Sobel Alan D. | Director | X | Common Stock | 21950 | $1.00 | 125,807.0000 | 54,434,609 | 21.13% | 0.04% |
| Jan. 17, 2025 | Sobel Alan D. | Director | X | Subscription Rights (right to buy) | 21950 | $0.00 | 0.0000 | 54,434,609 | 100.00% | 0.04% |
| Jan. 17, 2025 | Sobel Alan D. | Director | J | Series A Right Warrants | 21950 | $0.00 | 21,950.0000 | 54,434,609 | 9999.99% | 0.04% |
| Jan. 17, 2025 | Sobel Alan D. | Director | J | Series B Right Warrants | 21950 | $0.00 | 21,950.0000 | 54,434,609 | 9999.99% | 0.04% |
| Jan. 17, 2025 | Chan Phillip P. | Chief Executive Officer | X | Common Stock | 90832 | $1.00 | 1,243,195.0000 | 54,434,609 | 7.88% | 0.17% |
| Jan. 17, 2025 | Chan Phillip P. | Chief Executive Officer | X | Subscription Rights (right to buy) | 90832 | $0.00 | 0.0000 | 54,434,609 | 100.00% | 0.17% |
| Jan. 17, 2025 | Chan Phillip P. | Chief Executive Officer | J | Series A Right Warrants | 90832 | $0.00 | 90,832.0000 | 54,434,609 | 9999.99% | 0.17% |
| Jan. 17, 2025 | Chan Phillip P. | Chief Executive Officer | J | Series B Right Warrants | 90832 | $0.00 | 90,832.0000 | 54,434,609 | 9999.99% | 0.17% |
| Jan. 17, 2025 | MARIANI PETER J | Chief Financial Officer | X | Common Stock | 32625 | $1.00 | 433,988.0000 | 54,434,609 | 8.13% | 0.06% |
| Jan. 17, 2025 | MARIANI PETER J | Chief Financial Officer | X | Subscription Rights (right to buy) | 32625 | $0.00 | 0.0000 | 54,434,609 | 100.00% | 0.06% |
| Dec. 13, 2024 | MARIANI PETER J | Chief Financial Officer | P | Common Stock | 20000 | $0.96 | 401,363.0000 | 54,453,006 | 5.24% | 0.04% |
| Dec. 12, 2024 | MARIANI PETER J | Chief Financial Officer | P | Common Stock | 20000 | $0.89 | 381,363.0000 | 54,453,006 | 5.53% | 0.04% |
| Dec. 11, 2024 | MARIANI PETER J | Chief Financial Officer | P | Common Stock | 11363 | $0.89 | 361,363.0000 | 54,453,006 | 3.25% | 0.02% |
| Oct. 4, 2024 | Deliargyris Efthymios | Chief Medical Officer | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 54,453,006 | 9999.99% | 0.09% |
| Oct. 4, 2024 | Capponi Vincent | President and COO | A | Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 54,453,006 | 9999.99% | 0.18% |
| Oct. 4, 2024 | Capponi Vincent | President and COO | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 54,453,006 | 9999.99% | 0.09% |
| Oct. 4, 2024 | Deliargyris Efthymios | Chief Medical Officer | A | Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 54,453,006 | 9999.99% | 0.18% |
| Aug. 14, 2024 | MARIANI PETER J | Chief Financial Officer | A | Common Stock | 65000 | $0.00 | 175,000.0000 | 54,306,041 | 59.09% | 0.12% |
| Aug. 14, 2024 | MARIANI PETER J | Chief Financial Officer | A | Common Stock | 175000 | $0.00 | 350,000.0000 | 54,306,041 | 100.00% | 0.32% |
| Aug. 14, 2024 | MARIANI PETER J | Chief Financial Officer | A | Stock Option (right to buy) | 80000 | $0.00 | 80,000.0000 | 54,306,041 | 9999.99% | 0.15% |
| Aug. 14, 2024 | MARIANI PETER J | Chief Financial Officer | A | Stock Option (right to buy) | 215000 | $0.00 | 215,000.0000 | 54,306,041 | 9999.99% | 0.40% |
| Aug. 14, 2024 | MARIANI PETER J | Chief Financial Officer | A | Common Stock | 110000 | $0.00 | 110,000.0000 | 54,306,041 | 9999.99% | 0.20% |
| April 2, 2024 | BLOCH KATHLEEN P. | Chief Financial Officer | A | Common Stock | 65000 | $0.00 | 532,941.0000 | 54,434,609 | 13.89% | 0.12% |
| April 2, 2024 | Jones Edward Raymond | Director | A | Stock Option (Right to Buy) | 22000 | $0.00 | 22,000.0000 | 54,434,609 | 9999.99% | 0.04% |
| April 2, 2024 | Deliargyris Efthymios | Chief Medical Officer | A | Common Stock | 61000 | $0.00 | 409,433.0000 | 54,434,609 | 17.51% | 0.11% |
| April 2, 2024 | Deliargyris Efthymios | Chief Medical Officer | A | Stock Option (Right to Buy) | 86000 | $0.00 | 86,000.0000 | 54,434,609 | 9999.99% | 0.16% |
| April 2, 2024 | Sobel Alan D. | Director | A | Stock Option (Right to Buy) | 22000 | $0.00 | 22,000.0000 | 54,434,609 | 9999.99% | 0.04% |
| April 2, 2024 | BLOCH KATHLEEN P. | Chief Financial Officer | A | Stock Option (Right to Buy) | 87000 | $0.00 | 87,000.0000 | 54,434,609 | 9999.99% | 0.16% |
| April 2, 2024 | BATOR MICHAEL G. | Director | A | Stock Option (Right to Buy) | 44000 | $0.00 | 44,000.0000 | 54,434,609 | 9999.99% | 0.08% |
| April 2, 2024 | Capponi Vincent | President and COO | A | Common Stock | 81000 | $0.00 | 665,134.0000 | 54,434,609 | 13.87% | 0.15% |
| April 2, 2024 | Capponi Vincent | President and COO | A | Stock Option (Right to Buy) | 101000 | $0.00 | 101,000.0000 | 54,434,609 | 9999.99% | 0.19% |
| April 2, 2024 | Kim Jiny | Director | A | Stock Option (Right to Buy) | 22000 | $0.00 | 22,000.0000 | 54,434,609 | 9999.99% | 0.04% |
| April 2, 2024 | Chan Phillip P. | Chief Executive Officer | A | Common Stock | 96000 | $0.00 | 1,164,704.0000 | 54,434,609 | 8.98% | 0.18% |
| April 2, 2024 | Chan Phillip P. | Chief Executive Officer | A | Stock Option (Right to Buy) | 124000 | $0.00 | 124,000.0000 | 54,434,609 | 9999.99% | 0.23% |
| March 29, 2024 | Capponi Vincent | President and COO | A | Stock Option (Right to Buy) | 48923 | $0.00 | 48,923.0000 | 44,656,391 | 9999.99% | 0.11% |
| March 29, 2024 | BLOCH KATHLEEN P. | Chief Financial Officer | A | Stock Option (Right to Buy) | 49038 | $0.00 | 49,038.0000 | 44,656,391 | 9999.99% | 0.11% |
| March 29, 2024 | Chan Phillip P. | Chief Executive Officer | A | Stock Option (Right to Buy) | 129998 | $0.00 | 129,998.0000 | 44,656,391 | 9999.99% | 0.29% |
| March 29, 2024 | Deliargyris Efthymios | Chief Medical Officer | A | Stock Option (Right to Buy) | 47088 | $0.00 | 47,088.0000 | 44,656,391 | 9999.99% | 0.11% |
| Dec. 13, 2023 | Sobel Alan D. | Director | P | Common Stock | 22557 | $1.33 | 103,857.0000 | 44,373,969 | 27.75% | 0.05% |
| Dec. 13, 2023 | Sobel Alan D. | Director | P | Common Stock Warrant (Right to Buy) | 7894 | $0.00 | 7,894.0000 | 44,373,969 | 9999.99% | 0.02% |
| Dec. 13, 2023 | Deliargyris Efthymios | Chief Medical Officer | P | Common Stock | 22557 | $1.33 | 348,433.0000 | 44,373,969 | 6.92% | 0.05% |
| Dec. 13, 2023 | Deliargyris Efthymios | Chief Medical Officer | P | Common Stock Warrant (Right to Buy) | 7894 | $0.00 | 7,894.0000 | 44,373,969 | 9999.99% | 0.02% |
| Dec. 13, 2023 | Capponi Vincent | President & COO | P | Common Stock | 18797 | $1.33 | 584,134.0000 | 44,373,969 | 3.32% | 0.04% |
| Dec. 13, 2023 | Capponi Vincent | President & COO | P | Common Stock Warrant (Right to Buy) | 6578 | $0.00 | 6,578.0000 | 44,373,969 | 9999.99% | 0.01% |
| Dec. 13, 2023 | BATOR MICHAEL G. | Director | P | Common Stock | 37594 | $1.33 | 125,394.0000 | 44,373,969 | 42.82% | 0.08% |
| Dec. 13, 2023 | BATOR MICHAEL G. | Director | P | Common Stock Warrant (Right to Buy) | 13157 | $0.00 | 13,157.0000 | 44,373,969 | 9999.99% | 0.03% |
| Dec. 13, 2023 | Jones Edward Raymond | Director | P | Common Stock | 7519 | $1.33 | 88,834.0000 | 44,373,969 | 9.25% | 0.02% |
| Dec. 13, 2023 | Jones Edward Raymond | Director | P | Common Stock Warrant (Right to Buy) | 2631 | $0.00 | 2,631.0000 | 44,373,969 | 9999.99% | 0.01% |
| Dec. 13, 2023 | BLOCH KATHLEEN P. | Chief Financial Officer | P | Common Stock | 37594 | $1.33 | 467,941.0000 | 44,373,969 | 8.74% | 0.08% |
| Dec. 13, 2023 | BLOCH KATHLEEN P. | Chief Financial Officer | P | Common Stock Warrant (Right to Buy) | 13157 | $0.00 | 13,157.0000 | 44,373,969 | 9999.99% | 0.03% |
| Dec. 13, 2023 | Kim Jiny | Director | P | Common Stock | 7519 | $1.33 | 77,819.0000 | 44,373,969 | 10.70% | 0.02% |
| Dec. 13, 2023 | Kim Jiny | Director | P | Common Stock Warrant (Right to Buy) | 2631 | $0.00 | 2,631.0000 | 44,373,969 | 9999.99% | 0.01% |
| Dec. 13, 2023 | Chan Phillip P. | Chief Executive Officer | P | Common Stock | 75188 | $1.33 | 1,068,704.0000 | 44,373,969 | 7.57% | 0.17% |
| Dec. 13, 2023 | Chan Phillip P. | Chief Executive Officer | P | Common Stock Warrant (Right to Buy) | 26315 | $0.00 | 26,315.0000 | 44,373,969 | 9999.99% | 0.06% |
| Sept. 18, 2023 | BLOCH KATHLEEN P. | Chief Financial Officer | A | Common Stock | 45000 | $0.00 | 442,347.0000 | 44,015,380 | 11.33% | 0.10% |
| Sept. 18, 2023 | BLOCH KATHLEEN P. | Chief Financial Officer | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 44,015,380 | 9999.99% | 0.07% |
| Aug. 4, 2023 | BATOR MICHAEL G. | Director | P | Common Stock | 1000 | $3.23 | 85,800.0000 | 44,015,380 | 1.18% | 0.00% |
| Aug. 7, 2023 | BATOR MICHAEL G. | Director | P | Common Stock | 1000 | $3.20 | 86,800.0000 | 44,015,380 | 1.17% | 0.00% |
| Aug. 7, 2023 | BATOR MICHAEL G. | Director | P | Common Stock | 1000 | $3.15 | 87,800.0000 | 44,015,380 | 1.15% | 0.00% |
| July 7, 2023 | BLOCH KATHLEEN P. | Interim CFO | A | Stock Option (Right to Buy) | 20000 | $0.00 | 20,000.0000 | 44,015,380 | 9999.99% | 0.05% |
| July 7, 2023 | Chan Phillip P. | Chief Executive Officer | A | Common Stock | 87000 | $0.00 | 1,006,548.0000 | 44,015,380 | 9.46% | 0.20% |
| July 7, 2023 | Chan Phillip P. | Chief Executive Officer | A | Stock Option (right to buy) | 112000 | $0.00 | 112,000.0000 | 44,015,380 | 50.00% | 0.25% |
| July 7, 2023 | Chan Phillip P. | Chief Executive Officer | A | Stock Option (right to buy) | 48000 | $0.00 | 48,000.0000 | 44,015,380 | 50.00% | 0.11% |
| July 7, 2023 | BATOR MICHAEL G. | Director | A | Stock Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 44,015,380 | 9999.99% | 0.09% |
| July 7, 2023 | Sobel Alan D. | Director | A | Stock Option (right to buy) | 20000 | $0.00 | 20,000.0000 | 44,015,380 | 9999.99% | 0.05% |
| July 7, 2023 | Jones Edward Raymond | Director | A | Stock Option (right to buy) | 20000 | $0.00 | 20,000.0000 | 44,015,380 | 9999.99% | 0.05% |
| July 7, 2023 | Kim Jiny | Director | A | Stock Option (right to buy) | 20000 | $0.00 | 20,000.0000 | 44,015,380 | 9999.99% | 0.05% |
| July 7, 2023 | Capponi Vincent | President & COO | A | Common Stock | 73000 | $0.00 | 576,153.0000 | 44,015,380 | 14.51% | 0.17% |
| July 7, 2023 | Capponi Vincent | President & COO | A | Stock Option (right to buy) | 91000 | $0.00 | 91,000.0000 | 44,015,380 | 9999.99% | 0.21% |
| July 7, 2023 | Capponi Vincent | President & COO | A | Stock Option (right to buy) | 42000 | $0.00 | 42,000.0000 | 44,015,380 | 9999.99% | 0.10% |
| July 7, 2023 | Deliargyris Efthymios | Chief Medical Officer | A | Common Stock | 55000 | $0.00 | 331,648.0000 | 44,015,380 | 19.88% | 0.12% |
| July 7, 2023 | Deliargyris Efthymios | Chief Medical Officer | A | Stock Option (right to buy) | 78000 | $0.00 | 78,000.0000 | 44,015,380 | 9999.99% | 0.18% |
| July 7, 2023 | Deliargyris Efthymios | Chief Medical Officer | A | Stock Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 44,015,380 | 9999.99% | 0.09% |
| May 25, 2023 | BLOCH KATHLEEN P. | Interim CFO | P | Common Stock | 1100 | $2.85 | 442,147.0000 | 43,676,435 | 0.25% | 0.00% |
| May 25, 2023 | BLOCH KATHLEEN P. | Interim CFO | P | Common Stock | 1100 | $2.84 | 443,247.0000 | 43,676,435 | 0.25% | 0.00% |
| May 25, 2023 | BLOCH KATHLEEN P. | Interim CFO | P | Common Stock | 1100 | $2.85 | 444,347.0000 | 43,676,435 | 0.25% | 0.00% |
| May 10, 2023 | BLOCH KATHLEEN P. | Interim CFO | P | Common Stock | 5000 | $3.06 | 436,047.0000 | 43,676,435 | 1.16% | 0.01% |
| May 10, 2023 | BLOCH KATHLEEN P. | Interim CFO | P | Common Stock | 2000 | $3.13 | 438,047.0000 | 43,676,435 | 0.46% | 0.00% |
| May 10, 2023 | BLOCH KATHLEEN P. | Interim CFO | P | Common Stock | 3000 | $3.17 | 441,047.0000 | 43,676,435 | 0.68% | 0.01% |
| April 4, 2023 | Capponi Vincent | See Remarks | M | Common Stock | 10000 | $2.88 | 511,989.0000 | 43,676,435 | 1.99% | 0.02% |
| April 4, 2023 | Capponi Vincent | See Remarks | M | Stock Option (right to buy) | 10000 | $0.00 | 0.0000 | 43,676,435 | 100.00% | 0.02% |
| April 3, 2023 | Chan Phillip P. | Chief Executive Officer | M | Common Stock | 30500 | $2.88 | 927,779.0000 | 43,676,435 | 3.40% | 0.07% |
| April 3, 2023 | Chan Phillip P. | Chief Executive Officer | M | Stock Option (right to buy) | 30500 | $0.00 | 0.0000 | 43,676,435 | 100.00% | 0.07% |
| Feb. 27, 2023 | Sobel Alan D. | Director | G | Common Stock | 2000 | $0.00 | 81,300.0000 | 43,573,215 | 2.52% | 0.00% |
| Feb. 27, 2023 | Sobel Alan D. | Director | G | Common Stock | 2000 | $0.00 | 81,300.0000 | 43,573,215 | 2.40% | 0.00% |
| Feb. 6, 2023 | Kraus Al | Director | M | Common Stock | 12000 | $2.65 | 142,046.0000 | 43,573,215 | 9.23% | 0.03% |
| Feb. 6, 2023 | Kraus Al | Director | M | Stock Option (right to buy) | 12000 | $0.00 | 0.0000 | 43,573,215 | 100.00% | 0.03% |